| Literature DB >> 26246165 |
Abstract
Among the many unknowns in the translational path to developing drugs for acute stroke, addressing the reproducibility of preclinical data is only one piece of a multifaceted and incomplete puzzle (Llovera et al., this issue).Entities:
Mesh:
Substances:
Year: 2015 PMID: 26246165 DOI: 10.1126/scitranslmed.aac9412
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956